Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baxter International Inc (BAX) vs InMode Ltd (INMD) Price & Performance

Baxter International IncTrade
InMode LtdTrade

Price performance (Past 24H)

Key statistics

Baxter International Inc vs InMode Ltd — how do they compare? Baxter International Inc trades at $26.9 (market cap $13.93B), while InMode Ltd trades at $15.19 (market cap $876.40M). The key difference: Baxter International Inc is far larger — about 15.9× InMode Ltd's market cap, and Baxter International Inc pays a 0.15% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.

BAXINMD
Market Cap
$13.93B$876.40M
Sector
HealthTechnology
52-Week High
$28.35$16.62
52-Week Low
$15.80$12.76
Enterprise Value
$21.45B$379.73M
Dividend Yield
0.15%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Baxter International Inc

Baxter International (BAX) trades at $27.05, down 2.03% today, with a bullish technical signal from moving averages but mixed oscillators. Recent Q2 2026 earnings beat expectations with EPS of $0.56 versus $0.37, and the company raised its 2026 guidance, reflecting operational improvements. However, fundamentals show challenges with a negative net income margin of -9.27% and elevated P/E of 87.85, though revenue trends are stabilizing near $11.5 billion for 2026.

The outlook is cautiously optimistic due to earnings beats and raised guidance, but high valuation and persistent losses pose risks. Analyst consensus is mixed with 42% buy ratings and a $25.43 price target below the current price, suggesting limited upside. Key risks include margin pressure and high debt levels, requiring sustained execution for stock appreciation.

InMode Ltd

INMD trades at $15.23, up 0.59% on the day, with a neutral technical signal and mixed earnings history including a Q1 2026 miss. Valuation ratios appear attractive with a P/E of 12.59 and EV/EBITDA of 5.43, while profitability remains strong with a net income margin of 20.69%. Recent news highlights an unsolicited acquisition offer from Steel Partners at $16.75 per share and ongoing shareholder disputes.

The stock presents a cautious opportunity given its undervaluation and robust cash flow, but risks include earnings volatility, governance tensions, and a securities fraud investigation. Analyst consensus is divided with 45% buy ratings, reflecting uncertainty around the acquisition outcome and future execution.

Returns comparison

Trailing returns across standard periods

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

Read more on INMD